Tryptophan Metabolism and Neurodegenerative Disease Mechanisms

Tryptophan is an essential aromatic amino acid that serves as a precursor for multiple biochemical pathways, notably the kynurenine and serotonergic routes, each yielding metabolites with distinct neuroactive properties. The kynurenine pathway generates both neuroprotective quinolinic acid derivatives and neurotoxic species such as 3-hydroxykynurenine, which can induce oxidative stress, excitotoxicity and neuroinflammation. Concurrently, the serotonin pathway produces serotonin and its downstream mediator melatonin, exerting modulatory effects on mood, circadian rhythms and neuronal survival. Emerging evidence highlights the role of gut microbiota in converting tryptophan into indolamines such as tryptamine, which may cross the blood–brain barrier and modulate neuronal protein synthesis via inhibition of tryptophanyl-tRNA synthetase. Dysregulation of these metabolic cascades contributes to the pathogenesis of Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders through mechanisms involving mitochondrial dysfunction, protein misfolding and chronic inflammation. The interplay between host diet, microbial composition and enzymatic activity underscores a complex gut–brain axis influencing central tryptophan availability and metabolite distribution. Elucidating these interconnections offers opportunities for therapeutic interventions aimed at restoring metabolic equilibrium, reducing neurotoxic burden and promoting neuroprotection.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Tryptophan Metabolism and Neurodegenerative Disease Mechanisms publication trend

The graph below shows the total number of articles in tryptophan metabolism and neurodegenerative disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Tryptophan: An essential amino acid and precursor to the kynurenine and serotonergic pathways.

Kynurenine pathway: A metabolic route converting tryptophan into neuroactive metabolites, including kynurenic acid and quinolinic acid.

Serotonergic metabolism: The conversion of tryptophan to serotonin and melatonin, influencing mood, sleep and neuronal function.

Tryptamine: A microbially derived indolamine that can inhibit protein synthesis by targeting tryptophanyl-tRNA synthetase.

Tryptophanyl-tRNA synthetase (TrpRS): An enzyme that charges tRNA with tryptophan, essential for ribosomal protein synthesis.

Gut–brain axis: The bidirectional communication network linking the gastrointestinal microbiota, immune system and central nervous system.

Neurodegeneration: Progressive loss of neuronal structure and function, often driven by protein misfolding, mitochondrial dysfunction and inflammation.

References

1. Neuroactive metabolites and bile acids are altered in extremely premature infants with brain injury. Cell Reports Medicine (2024).
2. Towards an Integrative Understanding of tRNA Aminoacylation–Diet–Host–Gut Microbiome Interactions in Neurodegeneration. Nutrients (2018).